Venture Capital Investment Trends In Pharma - Q4 2024
Summary
This report analyzes the venture capital (VC) investment activity in Q4 2024 in the Pharma sector.
The global pharma sector in Q4 2024 witnessed investments worth $6.3 billion, a decline of 0.1% compared to Q3 2024. In terms of investment volume, there was a rise of 6.2% to 171 VC investments in Q4 2024. Oncology was the top therapy area with 74 deals by 203 investors.
Scope
- This report provides an overview of VC investment activity globally in Q4 2024 in the Pharma sector involving biopharmaceutical drug companies.
- It identifies key trends, and the most notable deals announced in Q4 2024 in the Pharma sector.
- Companies that strategically invest in venture funding position themselves for success, while those that fail to adapt risk falling behind.
- This report provides an overview of global VC investment trends in the pharma sector from the past quarter, offering insights into the industry landscape and key market movements.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Pharma Venture Capital Activity in Q4 2024
- 3 Global VC Investment Trends in Pharma
- 4 Global Quarterly Funding Activity in Pharma
- 5 Notable Deals in Pharma
- 6 Global Mega Investments Trends in Pharma
- 7 Mega Investments Quarterly Funding Activity in Pharma
- 8 Global Investment Activity in Pharma by Deal Size
- 9 Global Investment Activity in Pharma by Deal Stages
- 10 Deal Activity in Pharma: Top Deal Stage Type Analysis
- 11 Pharma Regional Comparison - Q4 2024
- 12 Pharma Regional Investment Activity in Pharma by Value and Volume
- 13 Pharma Investment Review by Top 10 Countries
- 14 Top 10 Therapy Area Investment Review
- 15 Top Pharma Investors by Value in Q4 2024
- 16 Further Information
- 16.1 Methodology
- 17 Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook